Background

The Foreign-Trade Zones Board has received from the Puerto Rico Industrial Development Company, grantee of FTZ 7, a notification of proposed production activity at the Lilly Del Caribe Inc. facilities within subzone 7K in Carolina and Guayama, Puerto Rico. Lilly already has authority to produce finished pharmaceuticals and their intermediates, including the active ingredients humalog and duloxetine, at these facilities and the current request would add new finished products and foreign-status materials and components to the scope of authority. Comments on this request are due by May 3.

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.